45.31000 EUR
0.46
1.03%
Last update Dec 15, 8:08 AM CET
Main market
Day range
45.31000
45.31000
Previous close
44.85000
Open
45.31000
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
45.31
0.46
1.03%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.4B 2.4B 2.1B 1.8B
Cost of revenue 494.2M 514.9M 483.7M 470.5M
Gross profit 1.9B 1.9B 1.6B 1.4B
Operating expense
Research & development 636.4M 746.8M 649.6M 628.8M
Selling general and admin 859.4M 937.3M 854M 759.4M
Other operating expenses
Operating income 403.9M 158.1M 46.0M -74.3M
Non operating interest income
Income 63.8M 58.3M 18.0M 10.5M
Expense 10.5M 16.7M 15.4M 14.7M
Other income expense 4.5M -10.5M 101.6M 3.8M
Pretax income 461.5M 188.6M 149.6M -75.4M
Tax provision 97.9M 20.9M 8.0M -11.3M
Net income 363.6M 167.6M 141.6M -64.1M
Basic EPS 2.3 0.9 0.8 -0.4
Diluted EPS 2.2 0.9 0.8 -0.4
Basic average shares 161.9M 196.7M 193.3M 190.8M
Diluted average shares 161.9M 196.7M 193.3M 190.8M
EBITDA 545.6M 309.7M 163.3M 55.4M
Net income from continuing op. 363.6M 167.6M 141.6M -64.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 10 minutes

09:49
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).